Published Online: Monday, May 1, 2006

The federal courts have pulled the plug on another prominent importer of Canadian prescription drugs, ruling that Canada Care Drugs Inc should be permanently enjoined from shipping pharmaceuticals to patients in the United States. The court's action was taken in the wake of an undercover investigation by FDA officials seeking to prevent cross-border sales of prescription medicines.

The kinds of products purchased undercover by the FDA from Canada Care "are often shipped with inadequate instructions for use or in inappropriate quantities that facilitate use of the product without the input of a physician that is needed to assure that the product is used in a manner to prevent serious, and even fatal, consequences," the agency official said.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues